Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 1 of the 13 calendar months from Oct 2025 to Oct 2026: Jun 2026.
- Largest single sale: $1.3M (7,883 shares) of Neurocrine Biosciences Inc on Jun 5, 2026. Filing
- Last sale before this period: Mar 7, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Neurocrine Biosciences Inc (NBIX) | Director | May 28, 2004 | Sep 3, 2026 |
| Biogen (BIIB) | Director | Mar 24, 2010 | Jun 11, 2026 |
Also a director at
Recent filings
The last 4 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Sep 2, 2026, Neurocrine Biosciences Inc: 1,000 shares given away. 1 filing: 1
- Jun 9, 2026, Biogen: 1,505 shares awarded. 1 filing: 1
- Jun 5, 2026, Neurocrine Biosciences Inc: sold 25,000 shares for $4.1M, under a disclosed plan; 25,000 shares acquired by exercising options. 1 filing: 1
- May 21, 2026, Neurocrine Biosciences Inc: 3,318 shares vested. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.